MARKET

MTP

MTP

Midatech Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5380
+0.0130
+2.48%
Opening 15:35 05/16 EDT
OPEN
0.5000
PREV CLOSE
0.5250
HIGH
0.5480
LOW
0.4500
VOLUME
26.90K
TURNOVER
9.13K
52 WEEK HIGH
3.610
52 WEEK LOW
0.3800
MARKET CAP
10.60M
P/E (TTM)
-1.0834
1D
5D
1M
3M
1Y
5Y
90 Biggest Movers From Yesterday
  Losers
Benzinga · 6d ago
Midatech Pharma reports FY results
Midatech Pharma press release (NASDAQ:MTP): FY Cash and deposits at 31 December 2021 of £10.06M (2020: £7.55M). Net loss from continuing operations of £5.46M (2020: £22.19M loss). Net cash inflow
Seekingalpha · 04/26 06:46
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year end...
ACCESSWIRE · 04/26 06:00
Midatech Pharma receives noncompliance notice from Nasdaq
Midatech Pharma (NASDAQ:MTP) received a letter from the Listings Qualifications Department of the Nasdaq that it is not in compliance with the minimum bid price. The notification does not lead to immediate
Seekingalpha · 04/14 12:43
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
NASDAQ Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period o...
ACCESSWIRE · 04/14 12:10
Midatech Pharma Gets Nasdaq Non-Compliance Notification
MT Newswires · 04/14 10:52
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce an extension of its existing R&D colla...
ACCESSWIRE · 03/09 07:00
Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser
ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is pleased to announce the appointment of Strand Hanson Limite...
ACCESSWIRE · 03/08 10:00
More
No Data
Learn about the latest financial forecast of MTP. Analyze the recent business situations of Midatech Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.23%
Pharmaceuticals & Medical Research
+1.02%
Key Executives
Non-Executive Chairman
Rolf Stahel
Chief Executive Officer/Chief Financial Officer/Director
Stephen Stamp
Executive Vice President
Steve Damment
Chief Scientific Officer
Dmitry Zamoryakhin
Vice President
Kelly Conlon
Vice President
Paul Seaman
Other
Sam Barker
Other
Nitu Sharma
Other
Fiona Sharp
Non-Executive Director
Simon De Vries
Non-Executive Independent Director
Simon Turton
No Data
No Data
About MTP
Midatech Pharma PLC is a drug delivery technology company, which is focused on improving the bio-delivery and biodistribution of medicines. The Company has developed three in-house technology platforms, each with its own mechanism to improve delivery of medications to sites of disease. The Company's platform includes Q-Sphera platform, MidaSolve platform and MidaCore platform. Q-Sphera platform is a micro-technology used for sustained release to prolong and control the release of therapeutics over an extended period of time (from weeks to months). MidaSolve platform is a nanotechnology used to dissolve insoluble drugs, which can be administered in liquid form directly and locally into tumors. MidaCore platform is a nanotechnology used for targeting medications to sites of disease. It has a pipeline of approximately 10 earlier stage programmes, which includes MTD211, MTD214, MTD220, MTX213, MTX214, MTX216, MTX110, MTX110, MTX110 and MTX114.

Webull offers kinds of Midatech Pharma PLC-ADR stock information, including NASDAQ:MTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTP stock methods without spending real money on the virtual paper trading platform.